Liver Neoplasm
30
7
7
8
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.3%
4 terminated out of 30 trials
66.7%
-19.8% vs benchmark
10%
3 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (30)
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors
Prediction Model for MINS After Major Hepatobiliary Surgery
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Y-90 Treatment Response Using Transarterial Radioembolization
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma
Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors
Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections
Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization